Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
TRIUMPH-4: 8.8% at 9 mg, 20.9% at 12 mg
After adjusting for baseline risk factors, GLP-1 users had significantly lower recurrence rates than those using SGLT2 inhibitors or DPP-4 inhibitors
The STEP UP trial, a Phase 3b study published in The Lancet Diabetes & Endocrinology in 2025, evaluated a 7.2 mg weekly injection dose in over 1,400 adults with obesity (BMI of 30 or higher) and without diabetes
The capsule-based system allows fresh actives to be delivered during application for a refined skincare step
On Thursday, the Trump administration announced agreements with Eli Lilly and Novo Nordisk to reduce the prices of the companies GLP-1 drugs for Americans
US$ 21.98
US$ 20.89
US$ 29.66
US$ 20.88
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
